Kangmei Pharmaceutical has won the first-instance trial in a recovery rights dispute. The court ordered Ma Xingtian and Xu Dongjin to pay approximately 1.396 billion yuan to the company. Qiu Xiwei bears supplementary liability within the scope of about 142 million yuan, and Guangdong Zhengzhong Zhujiang Certified Public Accountants bears supplementary liability within the scope of about 141 million yuan. Previously, the company was ordered by the Guangzhou Intermediate People's Court to compensate 52,037 investors for investment losses of approximately 2.459 billion yuan due to financial fraud. After completing all compensation in the bankruptcy reorganization process, it filed a recovery lawsuit against the responsible parties. This first-instance judgment supported part of the company's recovery claims.
Kangmei Pharmaceutical Co LtdCourt ordered responsible parties to pay ~1.4 billion yuan to the company, recovering part of compensation paid for financial fraud.